Riggs Asset Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-374
| Closed | -$36.8K | – | 157 |
|
|
2025
Q2 | $36.8K | Hold |
374
| – | – | 0.01% | 195 |
|
|
2025
Q1 | $34.6K | Hold |
374
| – | – | 0.01% | 181 |
|
|
2024
Q4 | $33.8K | Hold |
374
| – | – | 0.01% | 172 |
|
|
2024
Q3 | $36.1K | Hold |
374
| – | – | 0.01% | 171 |
|
|
2024
Q2 | $34.3K | Hold |
374
| – | – | 0.01% | 161 |
|
|
2024
Q1 | $34.5K | Hold |
374
| – | – | 0.01% | 156 |
|
|
2023
Q4 | $35.6K | Sell |
374
-76
| -17% | -$7.1K | 0.01% | 154 |
|
|
2023
Q3 | $42K | Hold |
450
| – | – | 0.02% | 149 |
|
|
2023
Q2 | $41.1K | Hold |
450
| – | – | 0.01% | 153 |
|
|
2023
Q1 | $33.1K | Hold |
450
| – | – | 0.01% | 155 |
|
|
2022
Q4 | $37.6K | Hold |
450
| – | – | 0.02% | 143 |
|
|
2022
Q3 | $44K | Hold |
450
| – | – | 0.02% | 138 |
|
|
2022
Q2 | $47K | Hold |
450
| – | – | 0.02% | 136 |
|
|
2022
Q1 | $78K | Hold |
450
| – | – | 0.02% | 131 |
|
|
2021
Q4 | $73K | Hold |
450
| – | – | 0.02% | 143 |
|
|
2021
Q3 | $67K | Hold |
450
| – | – | 0.02% | 137 |
|
|
2021
Q2 | $110K | Hold |
450
| – | – | 0.03% | 123 |
|
|
2021
Q1 | $119K | Hold |
450
| – | – | 0.04% | 117 |
|
|
2020
Q4 | $132K | Sell |
450
-102
| -18% | -$26.2K | 0.04% | 95 |
|
|
2020
Q3 | $122K | Buy |
552
+102
| +23% | +$23.2K | 0.05% | 75 |
|
|
2020
Q2 | $89K | Hold |
450
| – | – | 0.04% | 79 |
|
|
2020
Q1 | $82K | Hold |
450
| – | – | 0.05% | 75 |
|
|
2019
Q4 | $75K | Hold |
450
| – | – | 0.03% | 106 |
|
|
2019
Q3 | $58K | Hold |
450
| – | – | 0.03% | 113 |
|
|
2019
Q2 | $55K | Hold |
450
| – | – | 0.03% | 115 |
|
|
2019
Q1 | $55K | Hold |
450
| – | – | 0.04% | 111 |
|
|
2018
Q4 | $53K | Hold |
450
| – | – | 0.04% | 99 |
|
|
2018
Q3 | $56K | Hold |
450
| – | – | 0.03% | 100 |
|
|
2018
Q2 | $38K | Hold |
450
| – | – | 0.02% | 123 |
|
|
2018
Q1 | $27K | Hold |
450
| – | – | 0.01% | 150 |
|
|
2017
Q4 | $24K | Hold |
450
| – | – | 0.01% | 157 |
|
|
2017
Q3 | $25K | Hold |
450
| – | – | 0.01% | 159 |
|
|
2017
Q2 | $28K | Hold |
450
| – | – | 0.01% | 165 |
|
|
2017
Q1 | $23K | Hold |
450
| – | – | 0.01% | 158 |
|
|
2016
Q4 | $19K | Hold |
450
| – | – | 0.01% | 159 |
|
|
2016
Q3 | $21K | Hold |
450
| – | – | 0.01% | 153 |
|
|
2016
Q2 | $23K | Hold |
450
| – | – | 0.01% | 148 |
|
|
2016
Q1 | $22K | Hold |
450
| – | – | 0.02% | 139 |
|
|
2015
Q4 | $18K | Hold |
450
| – | – | 0.01% | 153 |
|
|
2015
Q3 | $17K | Hold |
450
| – | – | 0.01% | 149 |
|
|
2015
Q2 | $18K | Hold |
450
| – | – | 0.01% | 173 |
|
|
2015
Q1 | $12K | Hold |
450
| – | – | 0.01% | 203 |
|
|
2014
Q4 | $13K | Hold |
450
| – | – | 0.01% | 201 |
|
|
2014
Q3 | $9K | Buy |
+450
| New | +$8.68K | 0.01% | 211 |
|
Other funds holding AMED
IA
MCI
HNB
Riggs Asset Management's AMED Position: Q3 2025 in Review
Riggs Asset Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 374 shares — an estimated $36.8K sold.
Riggs Asset Management first reported a position in AMED in Q3 2014 and held it in 44 quarters. The position peaked at $132K in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.
- Riggs Asset Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
- Riggs Asset Management sold 374 Amedisys shares in Q3 2025, an estimated $36.8K.
- Riggs Asset Management first reported a position in Amedisys in Q3 2014 and held it in 44 quarters.
- Riggs Asset Management's Amedisys position peaked at $132K in Q4 2020.
- 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.
Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.